Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Bayas A, Ouallet J C, Kallmann B, Hupperts R, Fulda U, Marhardt K, SMART study group
Expert Opin Drug Deliv. 2015 Jun 22:1-12. PMID: 26098143.Abstract